Press

Acarix to participate in Erik Penser Bank’s Company Day on August 24, 2023

23 Aug

Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce participation in the upcoming Erik Penser Bank Company Day on August 24, 2023. Company President and CEO, Helen Ljungdahl Round, will conduct a 15-minute presentation about Acarix, followed by a 10-minute Q&A session from 16:20-16:45 CET. The event will take place at Erik Penser Bank’s Headquarters at Apelbergsgatan 27 in Stockholm and will broadcast virtually via Erik Penser Bank’s YouTube channel. Click here to watch live https://www.youtube.com/live/M3odTHpOipI?feature=share

For more information contact:
Helen Ljungdahl Round, CEO, phone +1 267 809 1225, +46 730 770283, email [email protected] 
Christian Lindholm, CFO, phone +46 705 118333, email [email protected]

About Acarix

Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor System uses advanced acoustics and AI-technology to rule out CAD non-invasively in less than 10 minutes, with at least 96% certainty. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, [email protected]) is Certified Advisor of Acarix. For more information, please visit www.acarix.com. 

Attachments
Acarix to participate in Erik Penser Bank's Company Day on August 24, 2023

Tags:
,
Newer Acarix welcomes Dr. Deepak R. Talreja MD as new Medical Advisor
Back to list
Older Acarix: Providing Ease and Peace through Innovative Medical Solutions

Related Posts